Literature DB >> 18967618

Simultaneous determination of caffeine and non-steroidal anti-inflammatory drugs in pharmaceutical formulations and blood plasma by reversed-phase HPLC from linear gradient elution.

M J Martín1, F Pablos, A G González.   

Abstract

A reversed-phase HPLC procedure based on methanol-water gradient elution for determining caffeine and non-steroidal anti-inflammatory drugs with UV absorbance detection is proposed. Chromatographic operational conditions were selected by considering the peak resolution and the retention times of the first and last eluted compounds. The method was suitably validated and successfully applied to the determination of: caffeine, indoprofen, ketoprofen, naproxen, fenbufen and ibuprofen in blood plasma samples and several analgesic/antiphlogistic pharmaceutical formulations.

Entities:  

Year:  1999        PMID: 18967618

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  4 in total

1.  Development of Micellar HPLC-UV Method for Determination of Pharmaceuticals in Water Samples.

Authors:  Danielle Cristina da Silva; Cláudio Celestino Oliveira
Journal:  J Anal Methods Chem       Date:  2018-03-01       Impact factor: 2.193

2.  Novel Validated Stability-Indicating UPLC Method for the Estimation of Naproxen and its Impurities in Bulk Drugs and Pharmaceutical Dosage Form.

Authors:  Papanaboina Venkatarao; Morrisetty Nagendra Kumar; Maram Ravi Kumar
Journal:  Sci Pharm       Date:  2012-09-09

3.  Effects of acute caffeinated coffee consumption on energy utilization related to glucose and lipid oxidation from short submaximal treadmill exercise in sedentary men.

Authors:  Donrawee Leelarungrayub; Maliwan Sallepan; Sukanya Charoenwattana
Journal:  Nutr Metab Insights       Date:  2011-11-24

4.  Simultaneous determination of ascorbic acid and caffeine in commercial soft drinks using reversed-phase ultraperformance liquid chromatography.

Authors:  Fatma Turak; Remziye Güzel; Erdal Dinç
Journal:  J Food Drug Anal       Date:  2016-11-06       Impact factor: 6.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.